Waldemar Lernhardt, Ph.D., has extensive experience in the pharmaceutical and biotechnology sectors, holding key positions such as Senior VP Operations at MAXIA Pharmaceuticals, Inc. and President & CEO of Proveri Inc., where they developed biomarker-based diagnostic assays for prostate cancer. Currently, they serve as Vice President of Scientific Operations at GATC Health. Their academic background includes a Ph.D. in Immunology from Heidelberg University and significant research roles at renowned institutions, including the Sanford-Burnham Medical Research Institute. Over the years, Waldemar has been instrumental in advancing clinical developments in oncology, diabetes, and other therapeutic areas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices